HAVCR2 and neoplasm: Our study is in line with previous studies on other tumor models like the T3 methylcholanthrene-induced sarcomas showing that inhibitory markers like PD-1 and TIM-3 and activating receptors like ICOS are co-expressed on tumor-specific T cells [33].